Burning Rock Biotech (BNR) Other Operating Expenses (2019 - 2026)

Burning Rock Biotech's Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$6.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 6.02% year-over-year to -$6.0 million; the TTM figure through Mar 2026 stood at -$23.5 million (up 22.86% YoY), while the FY2025 annual figure was -$2.7 million, up 94.8% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$6.0 million, up from -$6.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was -$5.4 million in Q2 2025, with the low at -$15.8 million in Q2 2022.
• The 5-year median for Other Operating Expenses is -$7.0 million (2023), against an average of -$8.8 million.
• The sharpest annual moves came in 2022 and 2025: Other Operating Expenses tumbled 67.26% in 2022, then jumped 43.81% in 2025.
• Burning Rock Biotech's Other Operating Expenses stood at -$12.3 million in 2022, then soared by 43.22% to -$7.0 million in 2023, then slumped by 59.93% to -$11.2 million in 2024, then surged by 43.81% to -$6.3 million in 2025, then climbed by 5.19% to -$6.0 million in 2026.
• Business Quant data shows BNR's Other Operating Expenses at -$6.0 million in Q1 2026, -$6.3 million in Q4 2025, and -$5.9 million in Q3 2025.